Both in Lab Analytical Instruments
Bionano Genomics vs Harvard Bioscience
Over the past year BNGO returned −35.6% and HBIO returned +110.6%; their daily moves had a correlation of 0.04.
BNGO −35.6% HBIO +110.6%Growth of $1, one year, split-adjusted
| Metric | BNGO | HBIO |
|---|---|---|
| Price | $1.21 | $8.42 |
| Market cap | $14.2M | $38.3M |
| Today | −1.23% | +0.84% |
| 1 month | −30.3% | +5.8% |
| 6 months | +3.9% | +37.4% |
| Year to date | −21.2% | +25.9% |
| 1 year | −36.9% | +109.5% |
| Revenue growth (YoY) | +21.4% | +11.1% |
| Gross margin | 52.8% | 55.6% |
| Net margin | −90.8% | −12.8% |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | 0.4× |
| Net cash | $6.2M | -$30.2M |
| Dividend yield | — | — |
| Volatility (60d) | 70.5% | 36.2% |
| Short % of float | 12.8% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).